Testing of GFAP in serum can provide valuable information in both traumatic brain injury and stroke. It is also helpful for certain neurodegenerative and neuroinflammatory conditions.
We are now expanding our offering for GFAP by providing testing in serum. Additionally, serum and cerebrospinal fluid testing are being transferred to the SIMOA platform.
View the test
